Investor Update
Basel, 26 September 2011
Peginterferon alfa-2a “Pegasys®” Approved for Additional Indication of “Chronic Active Hepatitis B”
Dear Investor,
Basel, 26 September 2011
Peginterferon alfa-2a “Pegasys®” Approved for Additional Indication of “Chronic Active Hepatitis B”
Dear Investor,